2021
peer-review
Author response for "Maintenance of Glycemic Control with Liraglutide versus Oral Antidiabetic Drugs as Add‐on Therapies in Patients with Type 2 Diabetes Uncontrolled with Metformin Alone: A Randomized Clinical Trial in Primary Care ( LIRA‐PRIME )"
Jeff Unger, Margit S. Kaltoft, Kavitha Lakkole, Jayant Panda, Chethana Ramesh, Mehmet Sargın, Е. А. Smolyarchuk, Melissa Twine, Benjamin Ole Wolthers, Gizem Yarimbas, Marouan Zoghbi, Dennis D. O’Keefe, Murdo Ferguson, Anil Kumar Gupta, Ronald Akhras, Sean D. Peterson, Guy Chouinard, Sameh Fikry, Richard Tytus, David E. Crowley, Pierre Filteau, Sandra Barrera Silva, Alexander Lebrato González, Luis Gomez‐Botero, Ghanshyam Pangtey, S. Prabhu, Pooja Khosla, Arun Narayan, Anil Awasthi, Rohan Sequeria, Reema Kashiva, K. N. Manohar, Ashwini Joshi, Ajay Agarwal, S. S. Ramesh, Sanjay Kumar Agarwal, Dipti Chand, Dinesh Kumar Jain, Ram S Kaulgud, Arija Lace, Georges Bou Haidar, Marwan Zoghbi, Rania Sakr, Grace Abi Rizk, Tatiana Stepanova, Albina Golovach, Ruslan Sardinov, S. Yu. Martsevich, Branka Djuric‐Pejovic, Svetlana Manojlovic‐Kulovic, Jelena Bajic, Danica Bacanin‐Jovanovic, Snezana Stojilkovic, I. Kostič, Burcu Doğan, Mehmet Burak Aktuğlu, Özlem Ciğerli, Marshall W. Anderson, William Byars, David Butuk, Kenneth J. Cohen, Alexander Dela Llana, Ankur Doshi, Bryan E. Feldman, Neil Fraser, Michael Lillestol, Robert Hippert, Stuart Stoller, Lawrence R. Allen, Richard Beasley, Ramin Farsad, Horacio Hidalgo, Michael Soboeiro, Kenneth Blaze, William Simon, Eric Dedeke, Brian G. Everhart, Michelle Look, James Kahrs, Melissa Poindexter, Stephen Falkowski, Clancy Cone, Charles H. Crump, Richard F. W. Jackson, Augusto Focil, Terence Hart, Brent Hella, Susan P. Kemp, César Albarracín, Martin Schear, Dwayne Williams, Dwayne O. Williams, John O. Willis, Thomas Wolf, Jennifer Bellucci‐Jackson, Jonathan Condit, Munib Daudjee, Robert Detweiler, Michael P. DiGiovanna, Neil Farris, Matthew M. Finneran, Frank Fusco, Peter Gagianas, Sidney Gorton, Marvin Heuer, J. D. Ruiz Alvarez, Gary Korff, Joseph Lomboy, Richard S. Lorraine, Charles R. Lovell, Caroline Mbogua, Deirdre McMullen, Richard Murphy, Henry Naddaf, Thomas P. O’Connor, Stephen Ong, Bryce Palchick, David K. Pham, Marina Raikhel, Mercedes Samson, Horia Tatu, Henry Traylor, Jeffrey Unger, Dave Webster, Kathleen Mullan Harris, Steven R. Bauer, Gary Bedel, Mark Benson, Isaac Beshay, Rafael Canadas, Cathy Hurley, Thomas P. Davis, H. Jackson Downey, Gregory Haase, Lee Herman, Moises Issa, Randal Jacks, Curtis Jantzi, David H. Johnson, Ted Kubicki, Reginald Parker, Raman Purighalla, Thaddeus Riley, Gildardo Ceballos, Robert Schreiman, Robert Scott, Matthew A. Lewis, Amit Shah, Charles Sharpe, Kanagaratnam Sivalingam, Stephen W. Smith, Joseph L. Woolley, Dilawar Ajani, Eric G. Ball, Daniel Schlosser, Elmer Stout, Moshir Jacob, Bradley Block, Wilfred McKenzie, Carl Meisner, Timothy Kitchen, Daniel Koontz, Joseph Labuda, Howard Wenocur, Robert Broker, Zeeshan Shaikh, Marcy Goisse, David Headley, David M. Headley, Elba Perez‐Vargas, Christopher W.K. Chow, Alex Guevara, Ralph Wade, John Sibille, Ajit Shah, Kenneth R Fox, Vonda Houchin, John Sensenbrenner, Boyde Harrison, Otis Barnum, B.V. Weber, Joseph Risser, Steven Barag, Anita Mercado, Royce Solano, Steve Simpson, Kari Uusinarkaus, Jose Burbano, Richard Glover, Ciro Reyes, Julian Gonzalez, C. Sofley, Timothy Dao, Michael Winnie, Howard Ellison, Tarek Hassanein, Govinda Lohani, Jon McRae, Fadi Saba, James D. Shoemaker, Kelly Taylor, Miguel Á. Treviño, Hernan Salazar, Irene Sobolevsky, Daniel Pomposini, Garth Vaz, Mark Fredrick, Larry Berman, Gregory C. Allen, Maja Delibasic, Carl J. Griffin, Bram Wieskopf, Aron Schlau, Wayne Reynolds, S. Michael Sutton, Allen Geltzer, Matthew A. Hummel, Thomas Fiel, Scott Kaiser, David Francyk, Kevin Pounds, William Kirby, Peter Levins, Gregston Nelson, LIRA‐PRIME investigators
0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés
Le résumé fourni par la source
Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add‐on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care ( LIRA‐PRIME )
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Author response for "Maintenance of Glycemic Control with Liraglutide versus Oral Antidiabetic Drugs as Add‐on Therapies in Patients with Type 2 Diabetes Uncontrolled with Metformin Alone: A Randomized Clinical Trial in Primary Care ( LIRA‐PRIME )"
- Date Crossref
- 20/09/2021
- Éditeur
- Wiley
- Type
- peer-review
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les sujets associés
Diabetes Treatment and ManagementPharmaceutical Practices and Patient OutcomesHyperglycemia and glycemic control in critically ill and hospitalized patients